Scotiabank analyst Sung Ji Nam initiated coverage of Guardant Health with an Outperform rating and $36 price target.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on GH:
- Sell these stocks now, proven algorithm says
- Goldman says Guardant selloff, Exact Science rally an overreaction
- Guardant Health price target raised to $70 from $65 at BofA
- Guardant Health price target lowered to $70 from $83 at Cowen
- Guardant’s ‘optical miss’ presents ‘compelling’ entry point, says Morgan Stanley